ADGC Publications

Found 241 results
2014
Nelson PT, Estus S, Abner EL, Parikh I, Malik M, Neltner JH, Ighodaro E, Wang W-X, Wilfred BR, Wang L-S et al..  2014.  ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology.. Acta Neuropathol. 127(6):825-43.
Schreiber M., Bird T.D., Tsuang D.W..  2014.  Alzheimer’s Disease Genetics. Current Behavioral Neuroscience Reports. 1(4)
Sud R, Geller ET, Schellenberg GD.  2014.  Antisense-mediated Exon Skipping Decreases Tau Protein Expression: A Potential Therapy For Tauopathies.. Mol Ther Nucleic Acids. 3:e180.
Allen M, Kachadoorian M, Quicksall Z, Zou F, Chai HSeng, Younkin C, Crook JE, V Pankratz S, Carrasquillo MM, Krishnan S et al..  2014.  Association of MAPT haplotypes with Alzheimer's disease risk and MAPT brain gene expression levels.. Alzheimers Res Ther. 6(4):39.
Barral S, Cosentino S, Christensen K, Newman AB, Perls TT, Province MA, Mayeux R.  2014.  Common genetic variants on 6q24 associated with exceptional episodic memory performance in the elderly.. JAMA Neurol. 71(12):1514-9.
Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, J McCarten R, Malphurs J et al..  2014.  Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.. JAMA. 311(1):33-44.
Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang L-S et al..  2014.  Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.
Ruiz A, Heilmann S, Becker T, Hernández I, Wagner H, Thelen M, Mauleón A, Rosende-Roca M, Bellenguez C, Bis JC et al..  2014.  Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene.. Transl Psychiatry. 4:e358.
Samocha KE, Robinson EB, Sanders SJ, Stevens C, Sabo A, McGrath LM, Kosmicki JA, Rehnström K, Mallick S, Kirby A et al..  2014.  A framework for the interpretation of de novo mutation in human disease.. Nat Genet. 46(9):944-50.
McMillan CT, Toledo JB, Avants BB, Cook PA, Wood EM, Suh ER, Irwin DJ, Powers J, Olm C, Elman L et al..  2014.  Genetic and neuroanatomic associations in sporadic frontotemporal lobar degeneration.. Neurobiol Aging. 35(6):1473-82.
Barral S, Reitz C, Small SA, Mayeux R.  2014.  Genetic variants in a 'cAMP element binding protein' (CREB)-dependent histone acetylation pathway influence memory performance in cognitively healthy elderly individuals.. Neurobiol Aging. 35(12):2881.e7-2881.e10.
Escott-Price V, Bellenguez C, Wang L-S, Choi S-H, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A et al..  2014.  Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease.. PLoS One. 9(6):e94661.
Beecham GW, Hamilton K, Naj AC, Martin ER, Huentelman M, Myers AJ, Corneveaux JJ, Hardy J, Vonsattel J-P, Younkin SG et al..  2014.  Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias.. PLoS Genet. 10(9):e1004606.
Kauwe JSK, Bailey MH, Ridge PG, Perry R, Wadsworth ME, Hoyt KL, Staley LA, Karch CM, Harari O, Cruchaga C et al..  2014.  Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.. PLoS Genet. 10(10):e1004758.
Sherva R, Tripodis Y, Bennett DA, Chibnik LB, Crane PK, De Jager PL, Farrer LA, Saykin AJ, Shulman JM, Naj A et al..  2014.  Genome-wide association study of the rate of cognitive decline in Alzheimer's disease.. Alzheimers Dement. 10(1):45-52.
Borenstein AR, Wu Y, Bowen JD, McCormick WC, Uomoto J, McCurry SM, Schellenberg GD, Larson EB.  2014.  Incidence rates of dementia, Alzheimer disease, and vascular dementia in the Japanese American population in Seattle, WA: the Kame Project.. Alzheimer Dis Assoc Disord. 28(1):23-9.
Benitez BA, Jin SChih, Guerreiro R, Graham R, Lord J, Harold D, Sims R, Lambert J-C, J Gibbs R, Bras J et al..  2014.  Missense variant in TREML2 protects against Alzheimer's disease.. Neurobiol Aging. 35(6):1510.e19-26.
Carney RM, Kohli MA, Kunkle BW, Naj AC, Gilbert JR, Züchner S, Pericak-Vance MA.  2014.  Parkinsonism and distinct dementia patterns in a family with the MAPT R406W mutation.. Alzheimers Dement. 10(3):360-5.
Toledo JB, Van Deerlin VM, Lee EB, Suh ER, Baek Y, Robinson JL, Xie SX, McBride J, Wood EM, Schuck T et al..  2014.  A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.. Alzheimers Dement. 10(4):477-484.e1.
Jun G, Asai H, Zeldich E, Drapeau E, Chen CD, Chung J, Park J-H, Kim S, Haroutunian V, Foroud T et al..  2014.  PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation.. Ann Neurol. 76(3):379-92.
Wetzel-Smith MK, Hunkapiller J, Bhangale TR, Srinivasan K, Maloney JA, Atwal JK, Sa SM, Yaylaoglu MB, Foreman O, Ortmann W et al..  2014.  A rare mutation in UNC5C predisposes to late-onset Alzheimer's disease and increases neuronal cell death.. Nat Med. 20(12):1452-7.
Logue MW, Schu M, Vardarajan BN, Farrell J, Lunetta KL, Jun G, Baldwin CT, Deangelis MM, Farrer LA.  2014.  Search for age-related macular degeneration risk variants in Alzheimer disease genes and pathways.. Neurobiol Aging. 35(6):1510.e7-18.
Ramirez A, van der Flier WM, Herold C, Ramonet D, Heilmann S, Lewczuk P, Popp J, Lacour A, Drichel D, Louwersheimer E et al..  2014.  SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.. Hum Mol Genet. 23(24):6644-58.

Pages